As local governments move towards legalization of marijuana, many patients with RA and other chronic illnesses are curious about cannabis as a potential treatment option. For this reason, I was very interested to attend a talk at the 2017 American College of Rheumatology Annual Meeting called “Cannabis in Society and Medical Practice.”
Tuesday, January 23, 2018
Tuesday, January 9, 2018
For Previous Cancer Patients, Biologics Don’t Increase Risk
For those with RA, new research has demonstrated that treatment with biologic medications does not increase the risk of a second cancer malignancy.
Posted by ~Mariah~ at 10:40:00 AM No comments:
Thursday, January 4, 2018
Biosimilars: To Switch or Not to Switch? That Is The Question!
If you’re interested in new and emerging treatments for RA, you’ve probably at least heard the term “biosimilars.” But what exactly are biosimilars? And what should you do if your doctor recommends one?
Posted by ~Mariah~ at 1:41:00 PM No comments:
Labels: Biologics, Biosimilars
Subscribe to: Posts (Atom)